H. Con. Res. 70 (110th)Bill Overview

Support National Celiac Awareness Month and Research Funding

Concurrent ResolutionCommemorations|Autoimmune diseasesCommemorations
Cosponsors
Support
Democratic
Introduced
Feb 16, 2007
Discussions
Bill Text
Current stageCommittee

Referred to the Subcommittee on Health.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Concurrent ResolutionWhat this resolution actually does

This resolution expresses Congresss support for National Celiac Awareness Month and encourages screening, early detection, and more research funding for celiac disease. It asks Congress and relevant parties to work with health care providers and advocacy organizations to raise awareness and improve testing and care. It is a formal statement of Congresss position and does not by itself change law or create legal duties.

Passage rules

Concurrent resolutions are adopted by both the House and the Senate but are not sent to the President and do not become law. They express the views or coordinate actions of Congress but do not create binding legal requirements.

This concurrent resolution supports National Celiac Awareness Month, urges collaboration with health care providers and advocacy groups to encourage screening and early detection of celiac disease, and calls for increased Federal funding for celiac disease research.

The text also cites calls for standardized serologic tests, a standard gluten-free definition, and improved testing and labeling standards for gluten content.

Passage75/100

Nonbinding, narrow public-health resolution with minimal fiscal impact historically passes readily, though it requests unspecified funding increases.

CredibilityAligned

Relative to its intended legislative type, this concurrent resolution is primarily symbolic and well-constructed for that purpose: it provides clear problem framing and rationale for recognition and awareness. It expresses policy preferences (encouraging screening and increased funding) but stops short of prescribing or authorizing action.

Contention45/100

Liberal emphasizes equity, concrete funding, and insurance coverage.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Federal agenciesFederal agencies · Workers

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitRaises public and professional awareness, potentially increasing diagnosis rates and earlier treatment.
  • Federal agenciesEncourages more federal research funding, potentially accelerating scientific understanding and therapeutic development.
  • Potential benefitPromotes dietitian involvement and nutritional management, improving patient care and reducing complication risks.
Likely burdened
  • Potential burdenAs a nonbinding resolution, it may have limited practical effect without follow‑on funding or regulation.
  • Federal agenciesCalls for increased federal research funding could raise budgetary pressures or require reallocation of resources.
  • WorkersStandardizing testing and labeling could impose compliance costs on food manufacturers and testing laboratories.
03 · Why people split

Why the argument around this bill splits.

Liberal emphasizes equity, concrete funding, and insurance coverage.
Progressive90%

Strongly supportive.

Sees the resolution as a public-health and equity step to improve diagnosis, treatment, and labeling for people with celiac disease.

Would want concrete funding levels, insurance coverage for dietitian care, and protections for low-income patients; some implementation effects are speculative given the resolution's vagueness.

Leans supportive
Centrist70%

Generally supportive but cautious.

Views the resolution as sensible awareness raising and research prioritization, while noting it is mainly declaratory and lacks implementation detail.

Wants cost estimates, measurable goals, and coordination with existing NIH programs before backing substantial spending.

Leans supportive
Conservative30%

Cautiously approving of awareness efforts but skeptical of increased federal spending and new regulatory standards.

Prefers private-sector engagement and limited government action; would press to avoid mandatory labeling changes or unfunded federal commitments.

Some perceived benefits are modest and impacts speculative.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood75/100

Nonbinding, narrow public-health resolution with minimal fiscal impact historically passes readily, though it requests unspecified funding increases.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • No specific funding amounts or appropriation mechanism provided
  • Whether Senate will allocate floor time for a concurrent resolution
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Liberal emphasizes equity, concrete funding, and insurance coverage.

Nonbinding, narrow public-health resolution with minimal fiscal impact historically passes readily, though it requests unspecified funding…

Unlocked analysis

Relative to its intended legislative type, this concurrent resolution is primarily symbolic and well-constructed for that purpose: it provides clear problem framing and rationale for recognition and awareness. It expres…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis